In this webinar, Drs. Seegmiller and Savona will discuss the emergence of molecular diagnostic testing, especially the use of multi-gene panels by next-generation sequencing, in myelodysplastic syndrome (MDS). They will describe the opportunities and limitations of these tests in diagnosis and prognosis of MDS, and their potential impact on the clinical care and treatment of patients with these diseases.
- To understand the current approach to the diagnosis of MDS.
- To describe the potential and the limitations of applying molecular diagnostic testing in MDS.
- To discuss the impact of molecular diagnostic testing on the prognosis and treatment of patients with MDS.
Handout (PDF, 2.5 MB)
Adam Seegmiller, MD, PhD, FCAP
Michael Savona, MD